Natasha Williams

Natasha Williams

Auto-generated profile, based on publicly available information

Natasha Williams

Department of Population Health, New York University Grossman School of Medicine, New York

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
NWNatasha Williams
Natasha Williams
HTHaleigh Tutrow
Haleigh Tutrow
PPPaulo Pina
Paulo Pina
HBHayley M. Belli
Hayley M. Belli
GOGbenga Ogedegbe
Gbenga Ogedegbe
ASAntoinette Schoenthaler
Antoinette Schoenthaler
Urban areas throughout the United States have been hardest hit by the COVID-19 pandemic, contributing to a major focus on increasing vaccine uptake. Despite ongoing discourse about vaccine hesitancy, vaccine access among underserved populations is underexplored. As of March 10, 2021, the New York City (NYC) Department of Health and Mental Hygiene reported that 1 250 370 residents had received at least 1 dose of a COVID-19 vaccine, including 19% of the non-Hispanic White population compared with a rate of only 9% among those who identified as African American/Black and Hispanic/Latinx.1 In this analysis, we review access to COVID-19 vaccination sites in Brooklyn, the most populated borough in NYC, to better understand disparities in vaccination.

3 June 2011 in Educational Assessment
Verified
Journal Article
Closed access
TWTiffany A. Whittaker
Tiffany A. Whittaker
NWNatasha J. Williams
Natasha J. Williams
BDBarbara G. Dodd
Barbara G. Dodd
This study assessed the interpretability of scaled scores based on either number correct (NC) scoring for a paper-and-pencil test or one of two methods of scoring computer-based tests: an item pattern (IP) scoring method and a method based on equated NC scoring. The equated NC scoring method for computer-based tests was proposed as an alternative to item response theory IP scoring to improve consumers' understanding of reported scores. Results indicated that a test taker's performance level and the method used to report scores may adversely affect participants' correct interpretation of test scores. The IP score report made it difficult for participants to interpret the reported scores. The equated NC scoring method did not yield score reports that are any easier to understand than the IP scoring method.

1 July 2020 in JMIR Research Protocols
Verified
Journal Article
Open access
ACAlicia Chung
Alicia Chung
Azizi SeixasAzizi Seixas
Azizi Seixas
NWNatasha Williams
Natasha Williams
YSYalini Senathirajah
Yalini Senathirajah
RRRebecca S. Robbins
Rebecca S. Robbins
GJGirardin Jean-Louis
Girardin Jean-Louis
Background: Participation in clinical trials among people of color remains low, compared with white subjects. This protocol describes the development of "Advancing People of Color in Clinical Trials Now!" (ACT Now!), a culturally tailored website designed to influence clinical trial decision making among people of color. Objective: This cluster randomized study aims to test the efficacy of a culturally tailored website to increase literacy, self-efficacy, and willingness to enroll in clinical trials among people of color. Methods: ACT Now! is a randomized trial including 2 groups: (1) intervention group (n=50) with access to the culturally tailored website and (2) control group (n=50) exposed to a standard clinical recruitment website. Clinical trial literacy and willingness to enroll in a clinical trial will be measured before and after exposure to the website corresponding to their assigned group (intervention or control). Surveys will be conducted at baseline and during the 1-month postintervention and 3-month follow-up. Website architecture and wireframing will be informed by the literature and experts in the field. Statistical analysis will be conducted using a two-tailed t test, with 80% power, at.05 alpha level, to increase clinical trial literacy, self-efficacy, and willingness to enroll in clinical trials 3 months post intervention. Results: We will design a culturally tailored website that will provide leverage for community stakeholders to influence clinical trial literacy, self-efficacy, and willingness to enroll in clinical trials among racial and ethnic groups. ACT Now! applies a community-based participatory research approach through the use of a community steering committee (CSC). The CSC provides input during the research study conception, development, implementation, and enrollment. CSC relationships help foster trust among communities of color. ACT Now! has the potential to fill a gap in clinical trial enrollment among people of color through an accessible web-based website. This study was funded in July 2017 and obtained institutional review board approval in spring 2017. As of December 2019, we had enrolled 100 participants. Data analyses are expected to be completed by June 2020, and expected results are to be published in fall 2020. Conclusions: ACT Now! has the potential to fill an important gap in clinical trial enrollment among people of color through an accessible web-based website.

22 December 2019 in JMIR Preprints
Verified
Preprint
Open access
ACAlicia Chung
Alicia Chung
Azizi SeixasAzizi Seixas
Azizi Seixas
NWNatasha Williams
Natasha Williams
YSYalini Senathirajah
Yalini Senathirajah
RRRebecca S. Robbins
Rebecca S. Robbins
GJGirardin Jean-Louis
Girardin Jean-Louis
BACKGROUND Participation in clinical trials among people of color remains low, compared with white subjects. This protocol describes the development of “Advancing People of Color in Clinical Trials Now!” (ACT Now!), a culturally tailored website designed to influence clinical trial decision making among people of color. OBJECTIVE This cluster randomized study aims to test the efficacy of a culturally tailored website to increase literacy, self-efficacy, and willingness to enroll in clinical trials among people of color. METHODS ACT Now! is a randomized trial including 2 groups: (1) intervention group (n=50) with access to the culturally tailored website and (2) control group (n=50) exposed to a standard clinical recruitment website. Clinical trial literacy and willingness to enroll in a clinical trial will be measured before and after exposure to the website corresponding to their assigned group (intervention or control). Surveys will be conducted at baseline and during the 1-month postintervention and 3-month follow-up. Website architecture and wireframing will be informed by the literature and experts in the field. Statistical analysis will be conducted using a two-tailed t test, with 80% power, at .05 alpha level, to increase clinical trial literacy, self-efficacy, and willingness to enroll in clinical trials 3 months post intervention. RESULTS We will design a culturally tailored website that will provide leverage for community stakeholders to influence clinical trial literacy, self-efficacy, and willingness to enroll in clinical trials among racial and ethnic groups. ACT Now! applies a community-based participatory research approach through the use of a community steering committee (CSC). The CSC provides input during the research study conception, development, implementation, and enrollment. CSC relationships help foster trust among communities of color. ACT Now! has the potential to fill a gap in clinical trial enrollment among people of color through an accessible web-based website. This study was funded in July 2017 and obtained institutional review board approval in spring 2017. As of December 2019, we had enrolled 100 participants. Data analyses are expected to be completed by June 2020, and expected results are to be published in fall 2020. CONCLUSIONS ACT Now! has the potential to fill an important gap in clinical trial enrollment among people of color through an accessible web-based website. CLINICALTRIAL ClinicalTrials.gov NCT03243071; https://clinicaltrials.gov/ct2/show/NCT00102401 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/17589